Viewing nowMirtol Tablets 20 mg (Telmisartan)
Telmisartan 20mg
Tablet · Prescription medication
Withus Pharm. Co., Ltd.

MFDS item code 202500502 · Approved 2025.03.06 · Insurance code 660704000
Treatment of essential hypertension and prevention of cardiovascular disease in high-risk patients
This medication helps to control blood pressure in patients with essential hypertension. It is also used to reduce the risk of myocardial infarction, stroke, and cardiovascular mortality in patients over 55 years of age who have a history of coronary artery disease, peripheral arterial disease, stroke, or high-risk diabetes. It is particularly effective in patients who cannot take ACE inhibitors. This medication plays an important role in overall risk reduction for cardiovascular diseases. Therefore, it can be used as a medication that aids in blood pressure management and improvement of cardiovascular health.
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water, with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. After treatment is started, the maximum blood pressure-lowering effect is achieved in 4 ∼ 8 weeks when the dose is increased. This medication has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medication be administered orally at 80 mg once daily with water, with or without food. The effect of doses below 80 mg on reducing the risk of cardiovascular morbidity and mortality is unknown. When starting treatment with this medication to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medications may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication can cause serious harm to the fetus and newborn, so if pregnancy is confirmed, it should be discontinued immediately. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. Patients with severe liver impairment, biliary obstruction, or cholestasis should not take this medication. Patients with allergic reactions or a history of hereditary angioedema should also avoid using this medication. In diabetic patients with moderate to severe renal impairment, it is prohibited to take this medication alongside certain other medications. Elderly patients, those with hyperkalemia, and patients with mild to moderate liver dysfunction should use this medication cautiously and may require dose adjustments. Caution is also necessary for patients with heart valve disease or ischemic heart disease. This drug has a blood-lowering effect, and excessive blood pressure reduction could lead to risks of myocardial infarction or stroke. Patients with weak kidney function or renal artery stenosis should also use this medication cautiously, as there is a risk of worsening renal function, and monitoring is needed. This medication may increase the blood pressure-lowering effect when taken with other antihypertensive medications. Regular monitoring of potassium levels is necessary due to the potential for hyperkalemia. Special caution is required when used with potassium-sparing diuretics or potassium supplements, as potassium levels can become dangerously high. This medication can lead to serious side effects such as liver dysfunction, jaundice, angioedema, renal failure, shock, syncope; if symptoms occur, it should be discontinued immediately and medical attention sought. Caution is needed while driving or operating machinery as there is a possibility of dizziness or fainting. This medication contains sorbitol and is not suitable for patients with fructose intolerance. Women who are pregnant or planning to become pregnant should not take this medication, and nursing mothers are also advised to avoid it. This medication is not recommended for children under 18 years of age as safety and efficacy have not been established. Overdose may result in hypotension, dizziness, acute renal failure; immediate medical treatment should be sought. This medication should be kept out of reach of children, and transferring to another container can jeopardize quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly-closed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1°C and 30°C at room temperature to ensure the drug's efficacy is safely preserved.
White round tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 20mg
Tablet · Prescription medication
Withus Pharm. Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.